Atezolizumab,nivolumab,Pembrolizumab,Ipilimumab
merck,roche,bms
['start,(-starti),(-starte)', 'rcc,(-irccs),(-srcc),(-urcc)']
final conclusions by of adjuvant trearment in high rcc we need to start selecting patients for therapy #esmo22 
Uro Oncology
Engine of growth
Buenos Aires 
Argentina